Keyphrases
Adult T-cell Leukemia
100%
Lymphoma Cells
100%
Heat Shock Protein 90 Inhibitor
100%
NVP-AUY922
100%
AUY922
60%
Heat Shock Protein 90 (Hsp90)
30%
Apoptosis
20%
Cell Proliferation
20%
Tumorigenesis
20%
PIM Kinase
20%
Client Proteins
20%
Surrogate Marker
10%
Dose Effect
10%
Cell-to-cell
10%
Cell Cycle Arrest
10%
Malignancy
10%
Chemoresistant
10%
Serine-threonine Kinase
10%
Isoxazole
10%
Therapeutic Agents
10%
Cell Survival
10%
Kinase Family
10%
Chaperone
10%
Neoplasms
10%
Oncogene
10%
Novel Therapeutic Targets
10%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
10%
Multiple Functions
10%
Heat Shock Protein 70 (HSP70)
10%
G1 Phase
10%
Cyclin-dependent Kinase 4 (CDK4)
10%
Survivin
10%
Phospho-Akt
10%
Effects on Survival
10%
Cyclin-dependent Kinase 6 (CDK6)
10%
Moloney murine Leukemia Virus
10%
Integration Site
10%
Geldanamycin
10%
Viral Integration
10%
SGI-1776
10%
Multiple Clients
10%
PIM-1
10%
Pim Kinase Inhibitor
10%
Pharmacology, Toxicology and Pharmaceutical Science
T Cell Leukemia
100%
Heat Shock Protein 90 Inhibitor
100%
Luminespib
100%
Heat Shock Protein 90
30%
Carcinogenesis
20%
Neoplasm
10%
Casein Kinase
10%
Chaperone
10%
Fluorescence Activated Cell Sorting
10%
Aciclovir
10%
Human T-Lymphotropic Virus 1
10%
Survivin
10%
Disease Marker
10%
Phosphotransferase Inhibitor
10%
Moloney Murine Leukemia Virus
10%
Geldanamycin
10%
Isoxazole
10%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Heat Shock Protein 90 Inhibitor
100%
Heat Shock Protein
30%
Carcinogenesis
20%
Downregulation
20%
Upregulation
10%
Cell Proliferation
10%
Casein Kinase
10%
Cell Cycle Arrest
10%
Cell Cycle
10%
Cell Survival
10%
Kinase
10%
Oncogene
10%
Phosphotransferase
10%
Fluorescence Activated Cell Sorting
10%
Human T-Lymphotropic Virus 1
10%
Survivin
10%
Cell Cycle Checkpoint
10%
G1 Phase
10%
Moloney Murine Leukemia Virus
10%
Geldanamycin
10%